Literature DB >> 32201225

TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.

Fauziyya Muhammad1, Dawei Wang2, Trisha McDonald2, Marisa Walsh3, Kayla Drenen3, Alyssa Montieth3, C Stephen Foster4, Darren J Lee5.   

Abstract

Regulatory T cells (Tregs) are necessary to prevent autoimmune disease. As such, stable FoxP3 expression is required for the proper function of Tregs in the control of autoimmune disease. Different Treg subsets that utilize different mechanisms of suppression have been identified. The T-cell immunoglobulin immunoreceptor tyrosine-based inhibitory motif (TIGIT) is a relatively new Treg cell marker that has a suppressive function. We have previously identified the adenosine 2A receptor (A2Ar) as a requirement for the emergence of Tregs following resolution of autoimmune disease. Using a FoxP3-GFP-Cre reporter mouse, we identify FoxP3 and 'exFoxP3' cells, show FoxP3 and not exFoxP3 cells are suppressive. We further show FoxP3 cells express TIGIT, and are induced through A2Ar in healthy volunteers, but not patients with autoimmune disease. Furthermore, we show Tregs emerge in the target tissue at the onset of autoimmune disease in an A2Ar-dependent manner. In summary, we identify a novel subset of TIGIT+ Tregs that are induced through stimulation of the A2Ar.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A2Ar; Experimental autoimmune uveitis; TIGIT; Tregs

Year:  2020        PMID: 32201225      PMCID: PMC7266701          DOI: 10.1016/j.jaut.2020.102441

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  39 in total

Review 1.  Ocular immune privilege: therapeutic opportunities from an experiment of nature.

Authors:  J Wayne Streilein
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

Review 3.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

4.  Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study.

Authors:  De-Kuang Hwang; Yiing-Jeng Chou; Cheng-Yun Pu; Pesus Chou
Journal:  Ophthalmology       Date:  2012-07-17       Impact factor: 12.079

5.  Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.

Authors:  Nicole Joller; Jason P Hafler; Boel Brynedal; Nasim Kassam; Silvia Spoerl; Steven D Levin; Arlene H Sharpe; Vijay K Kuchroo
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

6.  Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2.

Authors:  Kenichi Namba; Nobuyoshi Kitaichi; Tomomi Nishida; Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

7.  Inducible immune regulation following autoimmune disease in the immune-privileged eye.

Authors:  Nobuyoshi Kitaichi; Kenichi Namba; Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2005-01-12       Impact factor: 4.962

8.  Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.

Authors:  Darren J Lee; Andrew W Taylor
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest.

Authors:  Eric B Suhler; Michael J Lloyd; Dongseok Choi; James T Rosenbaum; Donald F Austin
Journal:  Am J Ophthalmol       Date:  2008-12       Impact factor: 5.258

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606

View more
  3 in total

Review 1.  TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.

Authors:  Chenran Yue; Sheng Gao; Shuting Li; Zhouhang Xing; Hengrong Qian; Ying Hu; Wenqian Wang; Chunyan Hua
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

2.  Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses.

Authors:  Vikas Saxena; Wenji Piao; Lushen Li; Christina Paluskievicz; Yanbao Xiong; Thomas Simon; Ram Lakhan; C Colin Brinkman; Sarah Walden; Keli L Hippen; Marina WillsonShirkey; Young S Lee; Chelsea Wagner; Bruce R Blazar; Jonathan S Bromberg
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

3.  Combined Deficiency of the Melanocortin 5 Receptor and Adenosine 2A Receptor Unexpectedly Provides Resistance to Autoimmune Disease in a CD8+ T Cell-Dependent Manner.

Authors:  Trisha McDonald; Fauziyya Muhammad; Kayleigh Peters; Darren J Lee
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.